Our products are available in 61 countriesClick here to learn more
Egis activities extend to every field of the pharmaceutical value chainClick here to learn more
Egis is an innovation-oriented generic pharma company, one of the regional industry leaders.Click here to learn more
The project "Improving the living conditions of children in orphanages in Yaroslavl" was recognized as the best in the nomination "Projects to Support Socially Vulnerable Groups of People".
Two technology-intensive developments, carried out with state subsidies, were completed at Egis Pharmaceuticals PLC’s Körmend site (Hungary). The investments were inaugurated by Péter Szijjártó, Minister of Foreign Affairs and Trade, and by the company’s CEO, Dr. István Hodász on 15 October. In addition to a new packaging plant, Egis has also established a plant with special knowledge and technology requirements, typically suitable to manufacture oncology products. Thus, Egis is now able to implement all value-creating processes within the field of oncology, from development to active ingredient and finished product manufacturing.
Disinfection plays an important role in reducing the risk of infection. As a responsible company, Egis supports the safe operation of pharmacies in the coronavirus pandemic.
Please report any adverse events